HDAC1 is a target of miR-449 [12], a recent study showed that in lung cancer, miR-449 has a synergistic effect on growth arrest with HDAC inhibitor [15], providing new information about combination therapy with miRNA and c-Met inhibitors. The gene discussed is HDAC1; the disease is lung cancer.